已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Editorial. Interspinous spacers for lumbar stenosis: time for obsolescence?

医学 椎板切除术 腰椎管狭窄症 队列 神经源性跛行 椎管狭窄 外科 跛行 腰椎 金标准(测试) 狭窄 物理疗法 内科学 动脉疾病 血管疾病 脊髓 精神科
作者
Marjorie C. Wang,Mohammed Y. T. AlGhamdi
出处
期刊:Journal of neurosurgery [Journal of Neurosurgery Publishing Group]
卷期号:34 (4): 541-542 被引量:1
标识
DOI:10.3171/2020.8.spine201205
摘要

umbar spinal stenosis (LSS) is the most common indication for spine surgery in the elderly population.This condition is prevalent in approximately 47% of 60-to 69-year-old individuals and increases with age. 1 In the US, rates of surgery for LSS have rapidly increased over time. 2 Although open laminectomy has traditionally been considered the gold-standard procedure, associated complications, the need for general anesthesia, and resource utilization have led to development of other interventions.Interspinous distraction devices (IDDs) are one example.The X-Stop (Medtronic) was approved in 2005 by the US FDA for use in patients with 1-or 2-level LSS and symptoms that improve with flexion.In one study, results with the X-Stop were favorable at the 1-year outcome compared with those of nonsurgical management; 59% of the X-Stop cohort reported significant improvement in the symptom severity and physical function domains of the Zurich Claudication Questionnaire compared with 12% of the nonsurgical cohort, and the authors reported a 1-year reoperation rate of 6% in the X-Stop cohort. 3Other studies have compared X-Stop with lumbar laminectomy and found improvement in outcomes among both cohorts; however, reoperation rates were consistently noted to be significantly higher among the X-Stop cohort. 5,6Since X-Stop can be implanted in an outpatient setting under local anesthesia with shorter procedural times than those required for laminectomy, questions remain regarding whether this device could play a role in the treatment of LSS despite the high reoperation rate.In this issue of Journal of Neurosurgery: Spine, Borg et al. 4 present results of the United Kingdom Cost-Effectiveness and Quality of Life After Laminectomy or X-Stop (CELAX) open-label, randomized controlled trial.Cost was measured per patient episode and included device, operating time, and admission costs.Quality of life (QOL) was measured using the EQ-5D as the primary outcome.Both the laminectomy and X-Stop cohorts reported im-
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Joyi发布了新的文献求助10
1秒前
小蘑菇应助科研通管家采纳,获得10
2秒前
嘻嘻哈哈应助科研通管家采纳,获得10
2秒前
慕青应助科研通管家采纳,获得10
2秒前
Kao应助科研通管家采纳,获得10
2秒前
顾矜应助科研通管家采纳,获得10
2秒前
2秒前
情怀应助科研通管家采纳,获得10
2秒前
2秒前
打打应助科研通管家采纳,获得10
2秒前
脑洞疼应助科研通管家采纳,获得10
2秒前
陈航完成签到,获得积分10
3秒前
大个应助xuezha采纳,获得10
3秒前
4秒前
两回事完成签到 ,获得积分10
4秒前
liu完成签到 ,获得积分10
4秒前
玩命的白猫完成签到,获得积分10
4秒前
我是老大应助Leeyee采纳,获得10
7秒前
研友_VZG7GZ应助qiqiqiqiqi采纳,获得10
7秒前
Parker发布了新的文献求助10
9秒前
9秒前
11秒前
11秒前
虚幻的百合关注了科研通微信公众号
11秒前
cc完成签到,获得积分10
13秒前
Hannibal发布了新的文献求助10
14秒前
FAPI发布了新的文献求助10
15秒前
15秒前
16秒前
Xue完成签到 ,获得积分10
17秒前
Leeyee发布了新的文献求助10
20秒前
nene完成签到,获得积分10
21秒前
开心孟完成签到,获得积分10
22秒前
Parker发布了新的文献求助10
22秒前
23秒前
23秒前
二十一完成签到,获得积分10
25秒前
星上尔烟完成签到 ,获得积分10
26秒前
大布完成签到,获得积分10
27秒前
能干的人完成签到,获得积分10
27秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Single Cell Analysis of the Tumor Microenvironment Landscape Across the Disease Spectrum of Multiple Myeloma 1000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场现状调查及投资机会研判报告 1000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场规模及竞争格局分析报告 1000
模型平均及其应用 900
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
The Cambridge History of China 英文版16册 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7330505
求助须知:如何正确求助?哪些是违规求助? 8944778
关于积分的说明 18974363
捐赠科研通 6985495
什么是DOI,文献DOI怎么找? 3216803
关于科研通互助平台的介绍 2383317
邀请新用户注册赠送积分活动 2196335